Proximagen flexes growing muscles on sturdy 2009 results
This article was originally published in Scrip
Executive Summary
Proximagen Neuroscience has posted strong full-year results on the back of its £50 million fundraising in June and the acquisition of Cambridge Biotechnology and certain programmes from Biovitrum in November.